Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boxer

Showing results (201-210 of 328) with videos related to

Pageof 33
Sort By:
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Rates of lobar atrophy in asymptomatic <i>MAPT</i> mutation carriersQin Chen, Bradley F Boeve, Matthew Senjem, et al.
Brain : a Journal of Neurology|November 3, 2020
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseasesDavid N Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, et al.
Alzheimer'S Research & Therapy|February 2, 2019
<sup>18</sup>F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Longitudinal functional network connectivity changes across the clinical stages of <i>C9orf72</i> hexanucleotide repeat expansion carriersLiwen Zhang, Suvi Häkkinen, Youjin Jung, et al.
Brain : a Journal of Neurology|November 21, 2023
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrumIgnacio Illán-Gala, Diego L Lorca-Puls, Boon Lead Tee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral ComplaintsMonica Rivera-Mindt, Micah J Savin, Vanessa Guzman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 9, 2012
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansionBaber K Khan, Jennifer S Yokoyama, Leonel T Takada, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from <i>GRN</i> gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.
Pageof 33

Showing results (201-210 of 328) with videos related to

Sort By:
Pageof 33
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Rates of lobar atrophy in asymptomatic <i>MAPT</i> mutation carriersQin Chen, Bradley F Boeve, Matthew Senjem, et al.
Brain : a Journal of Neurology|November 3, 2020
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseasesDavid N Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, et al.
Alzheimer'S Research & Therapy|February 2, 2019
<sup>18</sup>F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Longitudinal functional network connectivity changes across the clinical stages of <i>C9orf72</i> hexanucleotide repeat expansion carriersLiwen Zhang, Suvi Häkkinen, Youjin Jung, et al.
Brain : a Journal of Neurology|November 21, 2023
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrumIgnacio Illán-Gala, Diego L Lorca-Puls, Boon Lead Tee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral ComplaintsMonica Rivera-Mindt, Micah J Savin, Vanessa Guzman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 9, 2012
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansionBaber K Khan, Jennifer S Yokoyama, Leonel T Takada, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from <i>GRN</i> gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.
Pageof 33